Blankenbach, Germany

Regina Steigerwald

This inventor holds 1 USPTO granted patent. Top assignee: Degussa Aktiengesellschaft. Active years: 1984.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Regina Steigerwald: Innovator in Optically Active Proline Derivatives

Introduction

Regina Steigerwald is a notable inventor based in Blankenbach, Germany. She has made significant contributions to the field of chemistry, particularly in the development of optically active proline derivatives. Her work has implications for various applications, including liquid chromatography.

Latest Patents

Regina Steigerwald holds a patent for an "Optically active proline derivative, process for its production and use." This invention is directed to an optically active proline derivative of a specific general formula. The process involves reacting an enantiomerically pure proline or 4-hydroxy-proline with an alkali metal alcoholate and an epoxide. The resulting optically active proline derivative can be utilized in metal ion chelate complexes as a chiral stationary phase for the separation of enantiomers through liquid chromatography. She has 1 patent to her name.

Career Highlights

Regina Steigerwald has worked with Degussa Aktiengesellschaft, a prominent company in the chemical industry. Her role at the company has allowed her to focus on innovative research and development in her field.

Collaborations

Throughout her career, Regina has collaborated with esteemed colleagues such as Eberhard Busker and Jurgen Martens. These collaborations have contributed to her success and advancements in her research.

Conclusion

Regina Steigerwald is a pioneering inventor whose work on optically active proline derivatives has made a significant impact in the field of chemistry. Her contributions continue to influence advancements in liquid chromatography and related applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…